182 related articles for article (PubMed ID: 9000037)
21. [Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease].
Suda H
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):13-22. PubMed ID: 11185687
[TBL] [Abstract][Full Text] [Related]
22. [Recent aspects of Neuro-Behcet's disease].
Hirohata S
Brain Nerve; 2013 Nov; 65(11):1245-53. PubMed ID: 24200602
[TBL] [Abstract][Full Text] [Related]
23. Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.
Belghith M; Maghrebi O; Ben Laamari R; Hanachi M; Hrir S; Saied Z; Belal S; Driss A; Ben Sassi S; Boussoffara T; Barbouche MR
Cytokine; 2024 Jul; 179():156617. PubMed ID: 38631183
[TBL] [Abstract][Full Text] [Related]
24. Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.
Sumita Y; Murakawa Y; Sugiura T; Wada Y; Nagai A; Yamaguchi S
Scand J Immunol; 2012 Jun; 75(6):633-40. PubMed ID: 22340436
[TBL] [Abstract][Full Text] [Related]
25. Clinico-radiological findings of neuro-Behçet's syndrome.
Tajima Y; Homma S; Sinpo K; Maruo Y; Moriwaka F; Tashiro K
Intern Med; 1994 Mar; 33(3):136-41. PubMed ID: 8061388
[TBL] [Abstract][Full Text] [Related]
26. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.
Al-Araji A; Sharquie K; Al-Rawi Z
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):608-13. PubMed ID: 12700303
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of central nervous system lesions in Behçet's disease.
Hirohata S
J Neurol Sci; 2008 Apr; 267(1-2):41-7. PubMed ID: 17976652
[TBL] [Abstract][Full Text] [Related]
29. Cytological examination of cerebrospinal fluid in eight patients with neuro-Behçet's disease.
Nakamura S; Takase S; Itahara K
Tohoku J Exp Med; 1980 Dec; 132(4):421-30. PubMed ID: 6167023
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.
Hirohata S; Kikuchi H; Sawada T; Nagafuchi H; Kuwana M; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2012 Jun; 22(3):405-13. PubMed ID: 21935641
[TBL] [Abstract][Full Text] [Related]
31. [A case of chronic progressive neuro-Behcet's disease with cerebellar ataxia and bulbar palsy preceding mucocutaneo-ocular symptoms].
Watanabe M; Kobayashi R; Hasegawa T; Yokoi S; Okada H; Okuda S
Rinsho Shinkeigaku; 2018 Feb; 58(2):105-110. PubMed ID: 29386494
[TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance of the encephalon in 17 patients with ocular Behçet's disease].
Di Biasi C; Accorinti M; Trasimeni G; Pivetti Pezzi P; Melone A; Gualdi G
Radiol Med; 1997 Apr; 93(4):348-51. PubMed ID: 9244909
[TBL] [Abstract][Full Text] [Related]
33. Treatment of neuro-Behçet's disease: an update.
Borhani Haghighi A
Expert Rev Neurother; 2009 Apr; 9(4):565-74. PubMed ID: 19344307
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease.
Saruhan-Direskeneli G; Yentür SP; Mutlu M; Shugaiv E; Yesilot N; Kürtüncü M; Akman-Demir G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):25-7. PubMed ID: 23558092
[TBL] [Abstract][Full Text] [Related]
35. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
[TBL] [Abstract][Full Text] [Related]
36. Third complement component in cerebrospinal fluid in neuro-Behçet's syndrome. Conversion patterns by crossed immunoelectrophoresis.
Aoyama J; Inaba G; Shimizu T
J Neurol Sci; 1979 Apr; 41(2):183-90. PubMed ID: 86603
[TBL] [Abstract][Full Text] [Related]
37. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
38. [A case of chronic progressive neuro-Behçet disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with infliximab].
Hamada K; Takei R; Sakiyama Y; Moriyama H; Hashiguchi A; Takashima H
Rinsho Shinkeigaku; 2018 Jan; 58(1):30-34. PubMed ID: 29269695
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Hamzaoui K; Maître B; Hamzaoui A
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
